ZC3H18 and Burkitt lymphoma: In this way, ZC3H18 may contribute both to NF-κB components (thereby stabilizing MYC) and to NF-κB signaling in LMP1-expressing tumors while contributing to MYC stability in EBV+ BL, i.e. in the absence of LMP1.